Screen%20Shot%202020-05-26%20at%2018.57_

 US Pentagon DARPA inspired

gradient.png
  • Developed for first responders as a result of the 2001 United States biological attack using weaponized anthrax known as Amerithrax.

  • The US Pentagon’s Defense Advanced Research Projects Agency (DARPA) and L-3 Communications (Formerly Titan Corp) participated in the development of BIT™ for the purpose of neutralization of this hard to kill spore.

  • Binary Ionization Technology® and intellectual patents owned by TOMI™ including a prototype SteraMist® design was purchased from L-3 Communications in mid-2013.  TOMI™ entered its start-up phase including commercial fabrication and government registrations (EPA and FDA) granted in 2017 and is now currently available for commercial sale.

Get in touch

COMPANY

HOW IT WORKS

CONTACT US

L3M International Pte. Ltd.

80 Marine Parade Rd.

#09-08 Parkway Parade

Singapore  449269

Tel. + 65  9646 2519

LT.Leong@L3M-International.com